CAPA that closes, not CAPA that lingers.
Root cause analysis, effectiveness checks, and CAPA closure discipline — supported by dashboards and reviewer routing.
A corrective and preventive action programme turns quality events into investigated root causes, actions that address them, and evidence that the actions worked. The common failure is not recording CAPAs but closing them — effectiveness checks that were never performed, and root causes that describe the symptom rather than the cause.
Outcomes you can expect
- CAPA closure discipline
- RCA quality lift
- Effectiveness-check evidence
CAPA Programme Design is delivered by our regulatory services practice. Where it saves time, the team uses our products: GxP Copilot for validation lifecycle work and TraceDraft for clinical documentation.
Explore related capabilities: Regulatory Compliance, Regulatory Intelligence, Regulatory Information Management (RIM), eQMS Implementation & Validation.
The CAPA Backlog Problem: Why CAPAs Fail to Close
CAPA backlog — the accumulation of open CAPAs past their target closure date — is the single most visible indicator of a dysfunctional quality system. It is also one of the most commonly cited findings in FDA quality system inspections and ISO 13485 audits. The causes are consistent: CAPAs are opened reactively in response to individual deviations without a root cause that the corrective action actually addresses; action items are assigned to individuals without timeline accountability; effectiveness checks are not defined at the time of CAPA initiation and are invented retrospectively when closure is due; and the quality function lacks a dashboard that gives management visibility into CAPA status before individual CAPAs become overdue.
Our CAPA programme design engagements address all four causes simultaneously. We redesign the CAPA initiation process to require root cause analysis before action assignment. We implement a CAPA management workflow with defined escalation rules that alert line managers and quality leadership to approaching and overdue CAPAs before they pass their target date. We establish effectiveness check criteria at the time of CAPA initiation — what evidence will demonstrate that the corrective action has actually eliminated the root cause. And we implement a CAPA KPI dashboard that gives quality leadership real-time visibility into CAPA health across the organisation.
Root Cause Analysis Methodology for GxP Deviations
Root cause analysis quality is the primary determinant of CAPA effectiveness. A CAPA whose corrective action addresses a symptom rather than the root cause will not prevent recurrence — and the same event will return in the next CAPA cycle. Effective root cause analysis for GxP deviations requires a structured methodology: the most widely used in pharma and medical device are the 5-Why analysis, fishbone (Ishikawa) diagramming, and fault tree analysis. Each has appropriate applications: 5-Why is effective for simple, linear causal chains; fishbone analysis is effective for complex events with multiple potential contributing causes; fault tree analysis is appropriate for safety-critical systems with binary failure states.
Our CAPA programme design includes root cause analysis methodology training for quality engineers and investigation leads, with practical case studies drawn from actual GxP deviation types: data integrity deviations, equipment calibration failures, environmental monitoring excursions, and process parameter excursions. We provide investigation report templates that structure the RCA documentation to produce both a defensible root cause conclusion and an action plan that directly addresses the identified root cause — making the connection between RCA and CAPA action explicit and traceable.
Sources
Primary documents referred to on this page, from their official publishers.
See it on your own system.
Bring a URS or a system. We show you the validation package it produces.
- We reply within one business day
- We run your URS live on the call
- You get a clear plan and scope